Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucilla Parnetti

Showing results (1-10 of 283) with videos related to

Pageof 29
Sort By:
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial EnrichmentLucilla Parnetti, Paolo Eusebi
Thescientificworldjournal|September 22, 2009
Cerebrospinal fluid biomarkers and prediction of conversion in patients with mild cognitive impairment: 4-year follow-up in a routine clinical settingAlessia Lanari, Lucilla Parnetti
Biomarkers in Medicine|August 25, 2011
Role of CSF biomarkers in the diagnosis of prodromal Alzheimer's diseaseLucilla Parnetti, Davide Chiasserini
Frontiers in Neurology|July 16, 2015
Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal VariationClaudia Cicognola, Davide Chiasserini, Lucilla Parnetti
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 27, 2002
Genetics of ischemic strokeMichele Venti, Lucilla Parnetti, Virgilio Gallai
Frontiers of Neurology and Neuroscience|July 28, 2016
Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's DiseasesLucilla Parnetti, Paolo Eusebi, Alberto Lleó
Expert Review of Neurotherapeutics|July 8, 2026
Can the integration of blood-based biomarkers into Alzheimer's disease diagnosis revolutionize the field?Lorenzo Gaetani, Giovanna Nardi, Lucilla Parnetti
Biomolecules|February 26, 2020
The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF BiomarkersFederico Paolini Paoletti, Lorenzo Gaetani, Lucilla Parnetti
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 7, 2020
Molecular profiling in Parkinsonian syndromes: CSF biomarkersFederico Paolini Paoletti, Lorenzo Gaetani, Lucilla Parnetti
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 30, 2019
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathiesSilvia Paciotti, Leonardo Gatticchi, Tommaso Beccari, et al.
Pageof 29

Showing results (1-10 of 283) with videos related to

Sort By:
Pageof 29
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial EnrichmentLucilla Parnetti, Paolo Eusebi
Thescientificworldjournal|September 22, 2009
Cerebrospinal fluid biomarkers and prediction of conversion in patients with mild cognitive impairment: 4-year follow-up in a routine clinical settingAlessia Lanari, Lucilla Parnetti
Biomarkers in Medicine|August 25, 2011
Role of CSF biomarkers in the diagnosis of prodromal Alzheimer's diseaseLucilla Parnetti, Davide Chiasserini
Frontiers in Neurology|July 16, 2015
Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal VariationClaudia Cicognola, Davide Chiasserini, Lucilla Parnetti
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 27, 2002
Genetics of ischemic strokeMichele Venti, Lucilla Parnetti, Virgilio Gallai
Frontiers of Neurology and Neuroscience|July 28, 2016
Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's DiseasesLucilla Parnetti, Paolo Eusebi, Alberto Lleó
Expert Review of Neurotherapeutics|July 8, 2026
Can the integration of blood-based biomarkers into Alzheimer's disease diagnosis revolutionize the field?Lorenzo Gaetani, Giovanna Nardi, Lucilla Parnetti
Biomolecules|February 26, 2020
The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF BiomarkersFederico Paolini Paoletti, Lorenzo Gaetani, Lucilla Parnetti
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 7, 2020
Molecular profiling in Parkinsonian syndromes: CSF biomarkersFederico Paolini Paoletti, Lorenzo Gaetani, Lucilla Parnetti
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 30, 2019
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathiesSilvia Paciotti, Leonardo Gatticchi, Tommaso Beccari, et al.
Pageof 29